Paquinimod
- Product Name
- Paquinimod
- CAS No.
- 248282-01-1
- Chemical Name
- Paquinimod
- Synonyms
- ABR25757;ABR 25757;ABR-25757;ABR?215757;Paquinimod;ABR?215757; ABR 215757; ABR215757; PAQUINIMOD.;ABR-25757,Inhibitor,ABR25757,inhibit,Paquinimod;ABR 25757;ABR-25757;ABR25757;PAQUINIMOD;248282-01-1;N,5-diethyl-4-hydroxy-1-methyl-2-oxo-N-phenylquinoline-3-carboxamide;N,5-diethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide
- CBNumber
- CB92498835
- Molecular Formula
- C21H22N2O3
- Formula Weight
- 350.41
- MOL File
- 248282-01-1.mol
Paquinimod Property
- Boiling point:
- 487.3±45.0 °C(Predicted)
- Density
- 1.267±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMSO:15.0(Max Conc. mg/mL);42.8(Max Conc. mM)
- form
- A solid
- pka
- 4.50±1.00(Predicted)
- color
- White to off-white
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
N-Bromosuccinimide Price
- Product number
- 28443
- Product name
- Paquinimod
- Packaging
- 1mg
- Price
- $55
- Updated
- 2024/03/01
- Product number
- 28443
- Product name
- Paquinimod
- Packaging
- 25mg
- Price
- $914
- Updated
- 2024/03/01
- Product number
- 28443
- Product name
- Paquinimod
- Packaging
- 5mg
- Price
- $224
- Updated
- 2024/03/01
- Product number
- 28443
- Product name
- Paquinimod
- Packaging
- 10mg
- Price
- $420
- Updated
- 2024/03/01
- Product number
- 1997DM
- Product name
- Paquinimod
- Packaging
- 5mg
- Price
- $146
- Updated
- 2021/12/16
Paquinimod Chemical Properties,Usage,Production
Uses
Paquinimod is a S100A9 inhibitor preventing S100A9 binding to TLR-4. Paquinimod reduces pathology in experimental collagenase-induced osteoarthritis. Paquinimod treatment of collagenase-induced OA (CIOA) resulted in significantly reduced synovial thickening (57%), osteophyte size at the medial femur (66%) and cruciate ligaments (67%) and cartilage damage at the medial tibia (47%) and femur (75%; n=7, untreated n=6). Paquinimod reduces leukocyte recruitment during sterile inflammation. Paquinimod also reduced priming of proinflammatory effector CD4(+) T cells.
Paquinimod Preparation Products And Raw materials
Raw materials
Preparation Products
Paquinimod Suppliers
- Tel
- --
- Fax
- --
- sales@ajchem.in
- Country
- India
- ProdList
- 6100
- Advantage
- 58